Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Hepatitis A vaccine

Article Abstract:

A US-approved vaccine to prevent hepatitis A appears to be safe and effective. Hepatitis A is a viral disease that is spread by consuming fecally-contaminated food or water or by direct fecal-oral contact. As people in the US age, they are increasingly likely to acquire hepatitis A infection and to develop immunity. As of mid-1995, a product called Havrix is the only hepatitis A vaccine available in the US. It is administered in .5 milliliter (ml) or 1 ml doses injected on two or three occasions. At least 80% of adults develop a protective immune response within 15 days after the first injection. A clinical study revealed that the vaccine was 90% effective and antibody levels suggest that protection will extend for approximately 10 years. Severe allergic reactions, headache, fever, nausea, and loss of appetite are rare side effects.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1995
Viral vaccines, Havrix (Vaccine)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Twinrix: a combination hepatitis A and B vaccine

Article Abstract:

A vaccine called Twinrix is now available in the US for preventing both hepatitis A and hepatitis B. The vaccine contains the same antigens as the hepatitis A vaccine Havrix and the hepatitis B vaccine Engerix-B. Twinrix has not been approved for use in children.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2001
Hepatitis B, Twinrix (Vaccine)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Argatroban for treatment of heparin-induced thrombocytopenia

Article Abstract:

The anticoagulant drug Argatroban can be used instead of heparin in patients with heparin-induced thrombocytopenia. Heparin-induced thrombocytopenia is an adverse effect of heparin, which is also an anticoagulant.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2001
Argatroban (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation, Product/Service Evaluation, Prevention, Hepatitis A, Product information, Belgium, GlaxoSmithKline Inc.
Similar abstracts:
  • Abstracts: Management of fever in patients with cancer and treatment-induced neutropenia. Side effects of adjuvant treatment of breast cancer
  • Abstracts: New Horizons in the Treatment of Osteoarthritis of the Knee. The Role of Knee Alignment in Disease Progression and Functional Decline in Knee Osteoarthritis
  • Abstracts: The Zavanelli maneuver for relief of abdominal dystocia associated with gastroschisis. Fetal protein loss in gastroschisis as an explanation of associated morbidity
  • Abstracts: Reactivation of unstable angina after the discontinuation of heparin. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
  • Abstracts: Delivering justice. A permanent police presence in hospital corridors would be a draconian step. Would tougher sentences deter violence against health staff?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.